There were no significant differences in non-macrolide antimicrobial resistance after treatment, although an increase in prevalence of bacteria carrying aminoglycoside (p= 0.064) and trimethoprim (p = 0.059) resistance was close to significance (Fig. 2 b).
← all excerpts
Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial.
1
—
—